- Theme Cancer Pharmacists, Integrative Oncology
- Resource Type Position Statement
- DATE 1 January 2015
Medical use of cannabis
This is a joint position statement of the Clinical Oncology Society of Australia and the Cancer Council Australia (CCA) on the use of medicinal cannabis in cancer.
Managing conditions induced by cancer and cancer treatment, especially in patients with advanced cancer who have responded poorly to conventional relief options, is a significant concern for cancer patients and their doctors. There is increasing interest, both internationally and in Australia, in the opportunities to use cannabis in cancer care, particularly to relieve side effects of cancer treatment. However, there is currently limited evidence to support the quality, safety and efficacy for use of cannabis in standard care.
The position statement is located on the Cancer Council Australia website. It is a position statement only and does not provide clinical advice about the use of medicinal cannabis in cancer.
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 19 hours ago
The COSA Annual Report 2024 is available now on our website. Read about progress being made towards our goal of quality multidisciplinary cancer care for all. With reports from the President, CEO, ASM Co-convenors, COSA Groups and Affiliated Organisations. bit.ly/3RBFxBH
Read More >
COSAoncology 7 days ago
Our March member newsletter is out now. Check your inbox or log into your COSA account for the latest COSA news, member updates, journal articles and events. bit.ly/4j4unRT
Read More >
COSAoncology 15 days ago
Check your inbox for the latest COSA Nutrition Group eNews. Or to subscribe, login to your COSA member account bit.ly/4cI0nc3 and update your preferences. Or members can view the eNews online anytime at bit.ly/4kYm5ww
Read More >
COSAoncology 20 days ago
The take-out from Cancer Survivorship 2025 from co-convenor Bogda Koczwara. The conference theme was building capability and capacity in survivorship care and research. Courage, conviction, communication and collaboration were also firmly on display. #Surv25
Read More >
COSAoncology 21 days ago
After two days of amazing participation from health professionals and consumers, co-convenor Michael Jefford is energised to build on the improvements we're seeing in survivorship care. #Surv25
Read More >
COSAoncology 22 days ago
Congratulations to Best of the Best Poster Winner at #Surv25, Daniel Johnstone from Cancer Voices SA, for his poster, 'Patient-Teachers: A cancer-consumer informed approach to using stories of lived experience in healthcare student education.'
Read More >
COSAoncology 22 days ago
Congratulations to Best of the Best Rapid Fire Oral Winner at #Surv25, Chad Han, for his presentation on 'Implementing a nurse-enabled, integrated, shared-care model involving specialists and GPs in breast cancer post-treatment follow up (EMINENT) bit.ly/4kGPtqS
Read More >
COSAoncology 22 days ago
Congratulations to the Best of the Best Oral Winner at #Surv25, Ben Smith from the Daffodil Centre, for his presentation on 'Addressing fear of cancer recurrence in routine care: Feasibility of implementing a clinical pathway.' Read the paper: bit.ly/3XHO49L
Read More >
COSAoncology 27 days ago
Cancer Survivorship 2025 - Day 1 of thought provoking presentations and stimulating discussions around important survivorship topics including financial toxicity, living with metastatic cancer, and providing tailored person-centred care. Bring on Day 2! #Surv25
Read More >
COSAoncology 28 days ago
Our 2025 National Cancer Survivorship Conference begins tomorrow. Be prepared for an exciting program showcasing innovations in survivorship care, research, advocacy and policy. Plus opportunities to meet, mingle and collaborate. bit.ly/3F6okgT #Surv25
Read More >